Treatment

Displaying 1 - 10 of 248

Micromotors safely release antibiotics in the stomach

Micromotors safely release antibiotics in the stomach
Nanoengineers at the University of California San Diego have demonstrated for the first time using micromotors to treat a bacterial infection in the stomach. These tiny vehicles, each about half the width of a human hair, swim rapidly throughout the stomach while neutralising gastric acid and then release their cargo of antibiotics at the desired pH. Researchers published their findings in Nature Communications.
18th August 2017

Pathology atlas could lead to personalised cancer treatment

Pathology atlas could lead to personalised cancer treatment
A unique pathology atlas is now being launched and made available to researchers all over the world. It maps cancer-related genes and opens up a new route towards personalised cancer treatment. The atlas project has been led by Professor Mathias Uhlén, SciLifeLab, KTH Royal Institute of Technology, in cooperation with colleagues from Uppsala University and elsewhere. The new pathology atlas is a major step forward for the dream of personalised cancer treatment.
18th August 2017

Therapeutic material could promote better tissue regeneration

Therapeutic material could promote better tissue regeneration
A research team led by UCLA biomolecular engineers and doctors has demonstrated a therapeutic material that could one day promote better tissue regeneration following a wound or a stroke. During the body’s typical healing process, when tissues like skin are damaged the body grows replacement cells. Integrins are class of proteins that are important in the cellular processes critical to creating new tissue.
17th August 2017


What causes targeted cancer therapies to deflect their aim?

What causes targeted cancer therapies to deflect their aim?
Broad inadequacies in a widespread biological concept that affects cancer research could be significantly deflecting the aim of such targeted drugs, according to a new study. A team exploring genetic mechanisms in cancer at the Georgia Institute of Technology has found evidence that a prevailing concept about how cells produce protein molecules, particularly when applied to cancer, could be erroneous as much as two-thirds of the time.
16th August 2017

An experimental treatment for heart fibrosis

An experimental treatment for heart fibrosis
Researchers report encouraging preclinical results as they pursue elusive therapeutic strategies to repair scarred and poorly functioning heart tissues after cardiac injury—describing an experimental molecular treatment for heart failure. In a study in the Journal of the American College of Cardiology, researchers at the Cincinnati Children's Heart Institute inhibited a protein that helps regulate the heart's response to adrenaline.
15th August 2017

Ultrasound controls delivery of local anaesthetic

Ultrasound controls delivery of local anaesthetic
According to the CDC, 91 people die from opioid overdoses every day in the U.S. Here in Massachusetts, the state has an opioid-related death rate that is more than twice the national average. “Opioid abuse is a growing problem in healthcare,” says Daniel Kohane, MD, PhD, a senior associate in critical care medicine at Boston Children’s and professor of anaesthesiology at Harvard Medical School.
11th August 2017

Boosting insulin levels with CRISPR and skin grafts

Boosting insulin levels with CRISPR and skin grafts
A research team based at the University of Chicago has overcome challenges that have limited gene therapy and demonstrated how their novel approach with skin transplantation could enable a wide range of gene-based therapies to treat many human diseases. In the journal Cell Stem Cell, the researchers provide "proof-of-concept." They describe a new form of gene-therapy - administered through skin transplants - to treat two related and extremely common human ailments: type-2 diabetes and obesity.
7th August 2017

VasQ device receives IDE approval to initiate clinical study

VasQ device receives IDE approval to initiate clinical study
Laminate Medical Technologies has announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). IDE approval allows Laminate to evaluate the safety and efficacy of VasQ in clinical trials in the United States, with the goal of obtaining FDA marketing approval. The prospective, multi-center, single-arm, open-label, 13-site study will enroll 129 male and female patients, 18 to 80 years old, who require creation of new brachiocephalic fistula.
4th August 2017

Ceramic skull implant contributes with ultrasound treatments

Ceramic skull implant contributes with ultrasound treatments
Ultrasound brain surgery has enormous potential for the treatment of neurological diseases and cancers, but getting sound waves through the skull and into the brain is no easy task. To address this problem, a team of researchers from the University of California, Riverside has developed a ceramic skull implant through which doctors can deliver ultrasound treatments on demand and on a recurring basis.
3rd August 2017

Peripheral Nerve Stimulator for pain relief cleared by FDA

Peripheral Nerve Stimulator for pain relief cleared by FDA
Xavant Technology has announced that the U.S. FDA cleared their Stimpod NMS460. With the U.S. patent awarded on proprietary hybrid pulsed radio frequency (PRF) waveform, this non-invasive neuromodulation device is focused on the symptomatic relief and management of chronic intractable pain, as well as an adjunctive treatment in the management of post-surgical pain, post-traumatic acute pain problems, and an adjunct for pain control due to rehabilitation.
3rd August 2017


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

SPE Offshore Europe 2017
5th September 2017
United Kingdom Aberdeen Exhibition & Conference Centre
EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
ON Semiconductor Power Seminars 2017
11th September 2017
United Kingdom
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham